ATE110958T1 - Verwendung von sertralin zur behandlung verfrühter ejakulation. - Google Patents

Verwendung von sertralin zur behandlung verfrühter ejakulation.

Info

Publication number
ATE110958T1
ATE110958T1 AT90309063T AT90309063T ATE110958T1 AT E110958 T1 ATE110958 T1 AT E110958T1 AT 90309063 T AT90309063 T AT 90309063T AT 90309063 T AT90309063 T AT 90309063T AT E110958 T1 ATE110958 T1 AT E110958T1
Authority
AT
Austria
Prior art keywords
sertraline
premature ejaculation
treat premature
ejaculation
treat
Prior art date
Application number
AT90309063T
Other languages
English (en)
Inventor
Peter A Bick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23583530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE110958(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE110958T1 publication Critical patent/ATE110958T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90309063T 1989-08-30 1990-08-17 Verwendung von sertralin zur behandlung verfrühter ejakulation. ATE110958T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/400,417 US4940731A (en) 1989-08-30 1989-08-30 Method of treating premature ejaculation using sertraline

Publications (1)

Publication Number Publication Date
ATE110958T1 true ATE110958T1 (de) 1994-09-15

Family

ID=23583530

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90309063T ATE110958T1 (de) 1989-08-30 1990-08-17 Verwendung von sertralin zur behandlung verfrühter ejakulation.

Country Status (19)

Country Link
US (1) US4940731A (de)
EP (1) EP0415613B1 (de)
JP (1) JPH0393718A (de)
KR (1) KR910004187A (de)
AT (1) ATE110958T1 (de)
AU (1) AU609664B1 (de)
CA (1) CA2024188C (de)
CY (1) CY1973A (de)
DE (1) DE69012261T2 (de)
DK (1) DK0415613T3 (de)
HK (1) HK219196A (de)
HU (1) HU213474B (de)
IE (1) IE63470B1 (de)
IL (1) IL95473A (de)
MY (1) MY106938A (de)
NZ (1) NZ235101A (de)
PH (1) PH26998A (de)
PT (1) PT95117B (de)
ZA (1) ZA906883B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU674602B2 (en) * 1993-09-14 1997-01-02 Hyung Ki Choi Pharmaceutical composition for prophylaxis and treatment of premature ejaculation
US5597826A (en) 1994-09-14 1997-01-28 Pfizer Inc. Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
US20030133974A1 (en) * 1997-07-01 2003-07-17 Curatolo William John Encapsulated solution dosage forms of sertraline
US20040208926A1 (en) * 1997-07-01 2004-10-21 Pfizer Inc Solubilized sertraline compositions
CA2290966C (en) 1997-07-01 2005-12-20 Pfizer Inc. Sertraline salts and sustained-release dosage forms of sertraline
US6228864B1 (en) 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US5922341A (en) * 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
US6037360A (en) * 1997-10-28 2000-03-14 Vivus, Incorporated Administration of 5-HT3 receptor antagonists to treat premature ejaculation
ES2209490T3 (es) * 1998-10-13 2004-06-16 Pfizer Products Inc. Concentrado oral de sertralina.
IL132500A0 (en) 1998-10-29 2001-03-19 Pfizer Prod Inc Stereoselective microbial reduction of a racemic tetralone
CA2365032A1 (en) * 1999-03-01 2000-09-08 Pfizer Limited 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
US6245782B1 (en) 1999-05-17 2001-06-12 Heartdrug Research L.L.C. Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
EP1671628B1 (de) * 1999-09-03 2012-10-03 APBI Holdings, LLC Selektive Serotonin-Aufnahme Inhibitoren mit schnellem Wirkungseintritt zur Behandlung von sexueller Dysfunktionen
JP2003518487A (ja) 1999-12-23 2003-06-10 ファイザー・プロダクツ・インク ヒドロゲル駆動型積層薬物製剤
GB0007884D0 (en) * 2000-03-31 2000-05-17 Pfizer Ltd Diphenyl ether compounds useful in therapy
US6448293B1 (en) 2000-03-31 2002-09-10 Pfizer Inc. Diphenyl ether compounds useful in therapy
CN1091096C (zh) * 2000-09-15 2002-09-18 哈尔滨健迪医药科技开发有限公司 舍曲林柠檬酸盐及其用于治疗哺乳动物早泄的用途
US6495154B1 (en) 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
JP4377585B2 (ja) 2001-03-16 2009-12-02 ディーエムアイ バイオサイエンシズ インコーポレイテッド 射精遅延の方法
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
AU2003903597A0 (en) * 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
EP1737473A4 (de) * 2004-04-19 2009-08-26 Noven Therapeutics Llc Lithium-kombinationen und relevante verwendungen
MXPA06012777A (es) * 2004-05-06 2007-02-14 Cydex Inc Formulaciones de sabor enmascarado que contienen sertralina y eter sulfoalquilico-ciclodextrina.
WO2007070779A2 (en) * 2005-12-13 2007-06-21 Trinity Laboratories, Inc. A method to treat premature ejaculation in humans
US7893053B2 (en) 2006-06-16 2011-02-22 Theracos, Inc. Treating psychological conditions using muscarinic receptor M1 antagonists
US20090005319A1 (en) * 2007-07-01 2009-01-01 Barone Jr Frank V Topical compositions for delaying ejaculation and methods of using the same
US9272671B2 (en) 2013-06-28 2016-03-01 Faurecia Interior Systems, Inc. Display screen arrangement and method of assembly

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029731A (en) * 1974-11-06 1977-06-14 Pfizer Inc. Aminophenyltetralin compounds
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4507323A (en) * 1984-07-25 1985-03-26 Burroughs Wellcome Co. Treatment of psychosexual dysfunctions
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline

Also Published As

Publication number Publication date
US4940731A (en) 1990-07-10
DE69012261D1 (de) 1994-10-13
CA2024188C (en) 1994-11-08
PT95117A (pt) 1991-05-22
EP0415613B1 (de) 1994-09-07
MY106938A (en) 1995-08-30
PT95117B (pt) 1997-05-28
IL95473A (en) 1995-08-31
PH26998A (en) 1993-02-01
HK219196A (en) 1997-01-03
HU905682D0 (en) 1991-03-28
EP0415613A3 (en) 1992-02-26
DE69012261T2 (de) 1995-01-12
JPH0393718A (ja) 1991-04-18
HU213474B (en) 1997-06-30
KR910004187A (ko) 1991-03-28
HUT58512A (en) 1992-03-30
DK0415613T3 (da) 1994-10-10
CA2024188A1 (en) 1991-03-01
IE63470B1 (en) 1995-04-19
EP0415613A2 (de) 1991-03-06
AU609664B1 (en) 1991-05-02
IE903123A1 (en) 1991-03-13
ZA906883B (en) 1992-04-29
NZ235101A (en) 1997-01-29
CY1973A (en) 1997-09-05

Similar Documents

Publication Publication Date Title
ATE110958T1 (de) Verwendung von sertralin zur behandlung verfrühter ejakulation.
DE69434431D1 (de) Methoden zur behandlung von muskelerkrankungen und muskelstörungen
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
DE69616376D1 (de) Verwendung von Tiagabin zur Behandlung von Schlafstörungen
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE69033903D1 (de) Verwendung von Sertraline zur Herstellung eines Arzneimittels zur Behandlung von obsessiv-kompulsiven Erkrankungen
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
ATE281841T1 (de) Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
ATE235237T1 (de) Sertralin zur behandlung von post-myocard-infarkt-patienten
DE69004529D1 (de) Verwendung von Sertralin zur Behandlung von Abhängigkeiten von chemischen Stoffen.
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
ATE207353T1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
MX9602793A (es) Uso de sertralina para tratar pacientes despues de un infarto de miocardio.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee